Trending...
- Silicon Box Ships 500M Units at High Yield, Expands Production Capacity for Panel-Level Packaging
- Autonomous Robotics Platform Expansion as Public Market Debut is Very Close: MBody AI Corp. (N A S D A Q: MBAI)
- UK Financial Ltd Makes History: Chainlink CRE Circulating Supply Verification Goes Live Across Its Complete Ecosystem Of Nine Exchange-Traded Tokens
TORONTO - PrAtlas -- An open Bayesian Causal Atlas now reports, for every disease it covers — including non-fatal conditions — the best-case modelled reduction achievable when all applicable beneficial interventions are combined under a Pearl structural-causal framework.
Longevity Research (longevityresearch.ca), an independent quantitative-research project, today released a cross-oracle analysis that computes, for each disease in its Bayesian Causal Atlas, the maximum modelled reduction in that disease's own endpoint when every applicable beneficial intervention is combined at full dose under the project's causal model.
The analysis covers 27 disease models in a single comparable table — spanning all-cause mortality, cardiovascular disease (18 phenotypes), cancer (18 sites), kidney disease, immunology (45 conditions), pulmonary disease, brain tumours, organ transplant, and more — and, unlike most mortality-focused work, it deliberately includes endpoints that are not death: allergy flares, kidney-function decline, disability progression, and other quality-of-life outcomes.
More on PrAtlas
Longevity Research is an independent, non-commercial quantitative-research project that applies Bayesian causal inference to the leading causes of mortality and to chronic disease. Its Bayesian Causal Atlas is a free, open set of interactive analyses intended for people managing serious illness, their caregivers, and researchers. The site runs no advertising and collects no user data.
https://longevityresearch.ca/
Longevity Research (longevityresearch.ca), an independent quantitative-research project, today released a cross-oracle analysis that computes, for each disease in its Bayesian Causal Atlas, the maximum modelled reduction in that disease's own endpoint when every applicable beneficial intervention is combined at full dose under the project's causal model.
The analysis covers 27 disease models in a single comparable table — spanning all-cause mortality, cardiovascular disease (18 phenotypes), cancer (18 sites), kidney disease, immunology (45 conditions), pulmonary disease, brain tumours, organ transplant, and more — and, unlike most mortality-focused work, it deliberately includes endpoints that are not death: allergy flares, kidney-function decline, disability progression, and other quality-of-life outcomes.
More on PrAtlas
- Igbozue Connecticut USA Celebrates 2026 Summer Family Picnic
- KT Medical Staffing Addresses the Questions Families Forget to Ask Before Bringing Private Nursing Care Home
- Private Autopsies Give Arizona Families Answers After Nursing Home and Care Facility Deaths
- OPUS Global Data Solutions Launches Food Trader Plus, Bringing Operational Control and Deal-Level Profit Visibility to Food Brokers
- Phinge CEO DeMaio Unveils Speech to Congress: User Data Sovereignty vs Tech Surveillance Capitalism, Asserting Foundational 2021 App-Less Patents & IP
Longevity Research is an independent, non-commercial quantitative-research project that applies Bayesian causal inference to the leading causes of mortality and to chronic disease. Its Bayesian Causal Atlas is a free, open set of interactive analyses intended for people managing serious illness, their caregivers, and researchers. The site runs no advertising and collects no user data.
https://longevityresearch.ca/
Source: ASCL
0 Comments
Latest on PrAtlas
- ASSIST Software Becomes One of the First European Companies Certified to ISO/IEC 42001
- The World's No.1 Superstar® Enters the Occult with New Track and Cinematic Visual "Under Your Spell"
- PricZone Launches Online Shopping Platform Offering Electronics, Gaming, and More
- Heritage at South Brunswick Introduces New Ferndale Floorplan: The Largest Single-Family Home Design in the Community
- Lineus Medical Elevates Leadership to Accelerate Growth After Breakthrough Clinical Results
- Gateway Center Arena Announces Duane Curry as General Manger
- XRPPower Expands Platform Security With Enhanced Brand Protection and Official Verification Standards
- Cuvo Health, the #1 White Label Telehealth Platform, Surpasses 300 Exclusive Providers Serving All 50 States
- RAS AP Consulting Expands Managed AP Governance™ Ecosystem, Launches Trademark Process, and Secures IFOL Speaker Invitation
- UK Financial Ltd Makes History: Chainlink CRE Circulating Supply Verification Goes Live Across Its Complete Ecosystem Of Nine Exchange-Traded Tokens
- International Rights Groups Raise Alarm Over Freedom of Religion and Expression in South Korea
- The City's Most Elegant Open-Air Dinner Party Returns September 12, 2026
- FDA Clears Major Regulatory Hurdle as Preservative-Free Ketamine Program Moves Within Reach of Commercialization: NRx Pharmaceuticals: (NAS DAQ: NRXP)
- Autonomous Robotics Platform Expansion as Public Market Debut is Very Close: MBody AI Corp. (N A S D A Q: MBAI)
- Loud! OOH calls for prize draw advertising standards as £1.3bn category moves outdoors
- Black Ribbon Productions Launches With Fearless 2026 Horror Slate
- Actor Dominic Pace Returns to Television and Film
- Opteamix welcomes Girish Ramachandra to its leadership team as Senior Vice President of Client Services
- Silicon Box Ships 500M Units at High Yield, Expands Production Capacity for Panel-Level Packaging
- Why Baton Rouge's Humid Climate Can Contribute to Carpenter Ant Damage — J&J Exterminating Explains How to Protect Your Home